Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXOI2O
|
||||
| Drug Name |
4-(4-methoxyphenyl)-2-methyl-7-(3-(4-(thiazol-2-yl)piperazin-1-yl)propoxy)-1,2,3,4-tetrahydroisoquinoline
|
||||
| Synonyms |
CHEMBL396981
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H34N4O2S
|
||||
| Canonical SMILES |
COc1ccc(cc1)C2CN(C)Cc3cc(OCCCN4CCN(CC4)c5nccs5)ccc23
|
||||
| InChI |
InChI=1S/C27H34N4O2S/c1-29-19-22-18-24(8-9-25(22)26(20-29)21-4-6-23(32-2)7-5-21)33-16-3-11-30-12-14-31(15-13-30)27-28-10-17-34-27/h4-10,17-18,26H,3,11-16,19-20H2,1-2H3
|
||||
| InChIKey |
WURDXGJSSCNLKT-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Histamine H3 receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.